Department of Physiology, The Wenner-Gren Institute, Arrhenius Laboratories F3, Stockholm University, Stockholm, Sweden.
Br J Pharmacol. 2012 Mar;165(5):1442-56. doi: 10.1111/j.1476-5381.2011.01647.x.
β-Adrenoceptor stimulation induces glucose uptake in several insulin-sensitive tissues by poorly understood mechanisms.
We used a model system in CHO-K1 cells expressing the human β(2)-adrenoceptor and glucose transporter 4 (GLUT4) to investigate the signalling mechanisms involved.
In CHO-K1 cells, there was no response to β-adrenoceptor agonists. The introduction of β(2)-adrenoceptors and GLUT4 into these cells caused increased glucose uptake in response to β-adrenoceptor agonists. GLUT4 translocation occurred in response to insulin and β(2)-adrenoceptor stimulation, although the key insulin signalling intermediate PKB was not phosphorylated in response to β(2)-adrenoceptor stimulation. Truncation of the C-terminus of the β(2)-adrenoceptor at position 349 to remove known phosphorylation sites for GPCR kinases (GRKs) or at position 344 to remove an additional PKA site together with the GRK phosphorylation sites did not significantly affect cAMP accumulation but decreased β(2)-adrenoceptor-stimulated glucose uptake. Furthermore, inhibition of GRK by transfection of the βARKct construct inhibited β(2)-adrenoceptor-mediated glucose uptake and GLUT4 translocation, and overexpression of a kinase-dead GRK2 mutant (GRK2 K220R) also inhibited GLUT4 translocation. Introducing β(2)-adrenoceptors lacking phosphorylation sites for GRK or PKA demonstrated that the GRK sites, but not the PKA sites, were necessary for GLUT4 translocation.
Glucose uptake in response to activation of β(2)-adrenoceptors involves translocation of GLUT4 in this model system. The mechanism is dependent on the C-terminus of the β(2)-adrenoceptor, requires GRK phosphorylation sites, and involves a signalling pathway distinct from that stimulated by insulin.
β-肾上腺素受体刺激通过尚未完全理解的机制诱导几种胰岛素敏感组织中的葡萄糖摄取。
我们使用表达人β(2)-肾上腺素受体和葡萄糖转运蛋白 4(GLUT4)的 CHO-K1 细胞模型系统来研究涉及的信号转导机制。
在 CHO-K1 细胞中,β-肾上腺素受体激动剂没有反应。将β(2)-肾上腺素受体和 GLUT4 引入这些细胞会导致对β-肾上腺素受体激动剂的葡萄糖摄取增加。GLUT4 易位发生在胰岛素和β(2)-肾上腺素受体刺激的反应中,尽管关键的胰岛素信号中间物 PKB 没有被β(2)-肾上腺素受体刺激磷酸化。β(2)-肾上腺素受体在位置 349 截断 C 末端以去除已知的 GPCR 激酶(GRK)磷酸化位点,或在位置 344 去除另外的 PKA 位点以及 GRK 磷酸化位点,不会显著影响 cAMP 积累,但会降低β(2)-肾上腺素受体刺激的葡萄糖摄取。此外,通过转染βARKct 构建体抑制 GRK 会抑制β(2)-肾上腺素受体介导的葡萄糖摄取和 GLUT4 易位,并且过表达激酶失活的 GRK2 突变体(GRK2 K220R)也会抑制 GLUT4 易位。引入缺乏 GRK 或 PKA 磷酸化位点的β(2)-肾上腺素受体表明,GRK 位点而非 PKA 位点对于 GLUT4 易位是必需的。
在该模型系统中,β(2)-肾上腺素受体的激活引起葡萄糖摄取增加涉及 GLUT4 的易位。该机制依赖于β(2)-肾上腺素受体的 C 末端,需要 GRK 磷酸化位点,并涉及与胰岛素刺激不同的信号通路。